A01K 2267/0337
Animal models for infectious diseases
A01K2267/0337 (Animal models for infectious diseases) appears on 245 US grants and 384 published applications in this corpus.
Search patents in A01K- Granted patents
- 245
- Published applications
- 384
- Assignees
- 249
- Inventors
- 854
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 9 | 0 |
| 1998 | 8 | 0 |
| 1999 | 10 | 0 |
| 2000 | 8 | 0 |
| 2001 | 9 | 2 |
| 2002 | 7 | 14 |
| 2003 | 13 | 21 |
| 2004 | 6 | 17 |
| 2005 | 6 | 27 |
| 2006 | 8 | 20 |
| 2007 | 8 | 16 |
| 2008 | 5 | 13 |
| 2009 | 10 | 14 |
| 2010 | 10 | 18 |
| 2011 | 3 | 17 |
| 2012 | 5 | 24 |
| 2013 | 8 | 11 |
| 2014 | 10 | 7 |
| 2015 | 7 | 17 |
| 2016 | 9 | 11 |
| 2017 | 4 | 13 |
| 2018 | 11 | 5 |
| 2019 | 6 | 14 |
| 2020 | 9 | 21 |
| 2021 | 7 | 15 |
| 2022 | 9 | 20 |
| 2023 | 8 | 14 |
| 2024 | 8 | 13 |
| 2025 | 8 | 12 |
| 2026 | 9 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Non-human animals having humanized Fc-gamma receptors29 Sep 2026US 12,745,761 B2Regeneron Pharmaceuticals, Inc.
- Non-human animals comprising a humanized ACE2 locus11 Aug 2026US 12,702,122 B2Regeneron Pharmaceuticals, Inc.
- Genetically modified non-human animals expressing human EPO4 Aug 2026US 12,696,884 B2Institute for Research in Biomedicine (IRB)
- Genetically modified non-human animals and methods of use thereof7 Jul 2026US 12,672,643 B2Institute for Research in Biomedicine (IRB)
- Non-human vertebrate comprising human liver cells transplanted therein and method for producing the same2 Jun 2026US 12,642,257 B2Central Institute for Experimental Animals
- Genetically Modified Non-Human Animals and Methods of Use Thereof8 Oct 2026US 2026/0305588 A1Institute for Research in Biomedicine (IRB)
- Non-Human Animals Expressing Humanized CD3 Complex13 Aug 2026US 2026/0231915 A1Regeneron Pharmaceuticals, Inc.
- Exosomal loading using hydrophobically modified oligonucleotides9 Jul 2026US 2026/0193678 A1University of Massachusetts
- Human tryptophanyl-trna synthetase transgenic mouse models4 Jun 2026US 2026/0150820 A1Centre for Virology, Vaccinology and Therapeutics Limited
- Methods for treating hepatitis b infection4 Jun 2026US 2026/0151421 A1Dicerna Pharmaceuticals, Inc.
Most cited
By later US patents
- Transgenic mice depleted in a mature lymphocytic cell-type491US 5,591,669 AGenPharm International, Inc. · 1997
- Transgenic mice depleted in mature T-cells and methods for making transgenic mice175US 5,175,384 AGenPharm International, Inc. · 1992
- G-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereof125US 5,939,320 ANew York University · 1999
- Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease122US 5,877,399 ARegents of the University of Minnesota · 1999
- Transgenic non-human animals depleted in a mature lymphocytic cell-type114US 6,023,010 AGenPharm International, Inc. · 2000